Conclusion of a patent trial involving discontinued trocar products by United States Surgical

Last tuesday marked the conclusion of a patent trial involving discontinued trocar products by United States Surgical, a market leader and innovator of minimally invasive surgical instruments.

Following an earlier February 2002 infringement ruling issued by the court, a jury awarded $43.5 million to Applied Medical Resources Corp., a company based in Rancho Santa Margarita, Calif. The jury ruled also that the earlier infringement was willful, a finding subject to potential increase in damages by the trial court. The trial court has yet to consider a motion to set aside the jury's verdict on willfulness.

The lawsuit involves the seal system used in some of US Surgical's former Versaport(TM) trocar and access devices. The Versaport(TM) products are no longer on the market and have been replaced by US Surgical's next generation Versaport(TM) Plus products.

"Now that we have this lawsuit involving these discontinued products behind us, we look forward to continuing to serve our customers with our current line of Versaport(tm) Plus trocar products, which are not impacted by this lawsuit," said Alan Panzer, US Surgical's president.

http://www.tyco.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.